Implementation of pharmaceutical development using multivariate analysis of multi-criteria optimization on the example of the stage of purification of oligohexamethyleneguanidine hydrosuccinate
https://doi.org/10.32362/2410-6593-2023-18-3-265-279
Abstract
Objectives. The study set out to use mathematical modeling, in particular the method of multifactorial analysis of multicriteria optimization (MAMO), in the development of a pharmaceutical product.
Methods. After carrying out experimental tests based on the proposed algorithmic sequence, the obtained data were interpreted using MAMO.
Results. The possibility of using MAMO to solve the applied problem of purifying oligohexamethyleneguanidine hydrosuccinate (OHMG-HS), considered as a pharmaceutical precursor for the creation of medicines, was demonstrated.
Conclusions. The expediency of using the proposed algorithm as a tool for pharmaceutical development is substantiated by identifying dependencies of the influence of purification conditions on the final content of admixtures in the target product.
About the Authors
D. O. ShatalovRussian Federation
Denis O. Shatalov, Can. Sci. (Pharm.), Associate Professor, Department of Biotechnology and Industrial Pharmacy
86, Vernadskogo pr., Moscow, 119571
ResearсherID H-9408-2013
Scopus Author ID 57060435900
K. N. Trachuk
Russian Federation
Kirill N. Trachuk, Student, Department of Biotechnology and Industrial Pharmacy
86, Vernadskogo pr., Moscow, 119571
A. V. Aydakova
Russian Federation
Anna V. Aydakova, Technologist
86, Vernadskogo pr., Moscow, 119571
D. A. Akhmedova
Russian Federation
Diana A. Akhmedova, Postgraduate Student, Department of Biotechnology and Industrial Pharmacy
86, Vernadskogo pr., Moscow, 119571
Scopus Author ID 57218775331
I. S. Ivanov
Russian Federation
Ivan S. Ivanov, Technologist
86, Vernadskogo pr., Moscow, 119571
Scopus Author ID 57372716000
D. S. Minenkov
Russian Federation
Dmitry S. Minenkov, Cand. Sci. (Phys.-Math.)
101, Vernadskogo pr., Moscow, 119526
ResearсherID M-8037-2015
Scopus Author ID 36010696700
I. Yu. Blazhevich
Russian Federation
Igor Yu. Blazhevich, Student, Faculty of Mechanics and Mathematics
1, Kolmogorova ul., Moscow, 119234
S. A. Kedik
Russian Federation
Stanislav A. Kedik, Dr. Sci. (Eng.), Professor, Head of the Department of Biotechnology and Industrial Pharmacy; General Director
86, Vernadskogo pr., Moscow, 119571
Scopus Author ID 7801632547
References
1. Singh K.S., Anand S., Dholpuria S., Sharma J.K., Shouche Y. Antimicrobial Resistance Paradigm and OneHealth Approach. In: Panwar H., Sharma C., Lichtfouse E. (Eds.). Sustainable Agriculture Reviews 46. Mitigation of Antimicrobial Resistance. 2020. V. 46. P. 1–32. https://doi.org/10.1007/978-3-030-53024-2_1
2. La-Rosa R., Johansen H.K., Molin S. Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution. Antibiotics. 2022;11(3):419. https://doi.org/10.3390/antibiotics11030419
3. Davydov D.S. The National Strategy of the Russian Federation for Preventing the Spread of Antimicrobial Resistance: Challenges and Prospects of Controlling One of the Global Biological Threats of the 21st Century. BIOpreparaty. Profilaktika, diagnostika, lechenie = BIOpreparations. Prevention, Diagnostics, Treatment. 2018;18(1):50–56 (in Russ.). https://doi.org/10.30895/2221-996X-2018-18-1-50-56
4. Kedik S.A., Shatalov D.O., Norin A.M., Belyakov S.V., Ivanov I.S., Aidakova A.V. Method for the separation of branched oligohexamethylenguanidine salts for their use as pharmaceutical substances (variants): RF Pat. RU2750869. Publ. 07.05.2021 (in Russ.).
5. Shatalov D.O., Kedik S.A., Belyakov S.V., Ivanov I.S., Aidakova A.V., Sedishev I.P. Method of producing branched oligohexamethylene guanidine salts having degree of purity sufficient for use thereof as pharmaceutical substance: RF Pat. RU2729421. Publ. 06.08.2020 (in Russ.).
6. Shatalov D.O., Kedik S.A., Ivanov I.S., et al. Development of a Promising Method for Producing Oligomeric Mixture of Branched Alkylene Guanidines to Improve Substance Quality and Evaluate their Antiviral Activity Against SARS-CoV-2. Molecules. 2021;26(11):3472. https://doi.org/10.3390/molecules26113472
7. Belyakov S.V., Kedik S.A., Krupenchenkova N.V., Demenyuk P.Yu., Shatalov D.O. The effect of branched oligo(hexamethylene)guanidine hydrochloride against clinically significant pathogens. Biofarmatsevticheskii zhurnal = Russ. J. Biopharml. 2019;11(6):28–37 (in Russ.).
8. Kedik S.A., Shatalov D.O., Panov A.V., Aidakova A.V., Ivanov I.S., Belyakov S.V. Combined drug preparation in form of solution for preparing spray for treating diseases of oral cavity: RF Pat. RU2687745. Publ. 16.05.2019 (in Russ.).
9. Kedik S.A., Shatalov D.O., Kovalenko A.V., Aidakova A.V. Ophthalmic preparation in the form of eye drops for preventing and treating infectious conjunctivitis caused by bacteria and viruses: RF Pat. RU2699377. Publ. 09.05.2019 (in Russ.).
10. Akhmedova D.A., Shatalov D.O., Ivanov I.S., Aydakova A.V., Herbst A., Greiner L., Kaplun A.P., Zhurbenko A.S., Kedik S.A. The use of microfluidic hardware in the synthesis of oligohexamethylene guanidine derivatives. Tonk. Khim. Tekhnol. = Fine Chem. Technol. 2021;16(4):307–317 (Russ., Eng.). https://doi.org/10.32362/2410-6593-2021-16-4-307-317
11. Braun D., Sherdron G., Kern V. Prakticheskoe rukovodstvo po sintezu i issledovaniyu svoistv polimerov (A Practical Guide to the Synthesis and Study of the Properties of Polymers): transl. from German. Moscow: Khimiya; 1976. 256 p. (in Russ.). [Brown D., Sherdron G., Kern V. Praktikum der Makromolekularen Organischen Chemie. Heidelberg: Alfred Huthig, 1971.]
12. Efimov K.M., Gembitskii P.A., Martynenko S.V. Method for purification polyguanidine disinfecting agent from parent monomers: RF Pat. RU2237682. Publ. 10.10.2004 (in Russ.).
13. Antony J. Design of Experiments for Engineers and Scientists. First edition. Elsevier Science & Technology Books; 2003. 156 p.
14. Grzhibovsky A.M. The choice of a statistical criterion for testing hypotheses. Ekologiya cheloveka = Human Ecology. 2008;(11):48–57 (in Russ.).
Supplementary files
|
1. Results of oligohexamethyleneguanidine hydrosuccinate optimization with carbon tetrachloride | |
Subject | ||
Type | Исследовательские инструменты | |
View
(106KB)
|
Indexing metadata |
- The possibility of using multifactorial analysis of multicriteria optimization to solve the applied problem of purifying oligohexamethyleneguanidine hydrosuccinate, considered as a pharmaceutical precursor for the creation of medicines, was demonstrated.
- The expediency of using the proposed algorithm as a tool for pharmaceutical development is substantiated by identifying dependencies of the influence of purification conditions on the final content of admixtures in the target product.
Review
For citations:
Shatalov D.O., Trachuk K.N., Aydakova A.V., Akhmedova D.A., Ivanov I.S., Minenkov D.S., Blazhevich I.Yu., Kedik S.A. Implementation of pharmaceutical development using multivariate analysis of multi-criteria optimization on the example of the stage of purification of oligohexamethyleneguanidine hydrosuccinate. Fine Chemical Technologies. 2023;18(3):265-279. https://doi.org/10.32362/2410-6593-2023-18-3-265-279